Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results
Published in Gene Therapy Weekly, March 12th, 2009
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY): – Established Human Proof of Concept with an RNAi Therapeutic, a First for the Industry – – Advanced Pipeline with ALN-RSV and ALN-VSP Clinical Programs – – Continued Scientific Leadership, Consolidation of Leading Intellectual Property, and Formed Four Major Alliances in Last 12 Months with $175 Million in Realized Funding – – Ended 2008 with $513 Million in Cash and Earned $96 Million in Revenues, a Near Doubling of 2007 Revenues – – Net Loss Narrowed in 2008 as Compared to 2007 Due to Strong Revenues – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, reported its consolidated financial results for the fourth...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-03-12)
More Articles from Gene Therapy Weekly
- University of California - Los Angeles
Gene therapy shows promise as weapon against HIV - Adenoid Cystic Cancer
Researchers at Hirosaki University, Medical Department have published new data on adenoid cystic cancer - Antisense Technology
Study findings on antisense technology are outlined in reports from T.J. Doran and colleagues - Anxiety Disorders
Studies from University of Alabama provide new data on anxiety disorders - Bioengineering
Reports on bioengineering findings from W.R. Hong and co-researchers provide new insights - Breast Cancer
Findings in breast cancer reported from J.A. Menendez and co-researchers - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
